Aktieanalys

InDex Pharmaceuticals: Update on cash position - Redeye

{newsItem.title}

Redeye Publicerad: 19 Jan 2024 15:59

Redeye makes minor adjustements to its valuation of InDex Pharmaceuticals following the announcement of anticipated end of Q1 2024 cash position. Even after the announcement, the share continue to trade with a discount compared to the cash position.

Länk till analysen i sin helhet: https://www.redeye.se/research/971427/index-pharmaceuticals-update-on-cash-position?utm_source=finwire&utm_medium=RSS

Nyheter om Flerie

Läses av andra just nu

Om aktien Flerie

Senaste nytt